Pneumonia Guide vs DAPT Risk Calculator

Pneumonia Guide distills and organizes the guidance found in the 2019, 2016, 2007, and 2005 American Thoracic Society & Infectious Disease Society of America guidelines on management of Community Acquired Pneumonia and Hospital Acquired Pneumonia and the 2011 IDSA Pediatric Community Acquired Pneumonia guideline. The app addresses such common questions as: * what criteria are useful in deciding which community acquired pneumonia patients should be hospitalized? * what are those big-gun antibiotics for adult hospital acquired pneumonia, and what are the alternatives for those with medication allergies? * how long should antibiotics be continued? * exactly which pneumonia cases are considered to be hospital acquired? * which community acquired pneumonia patients require coverage for resistant organisms? * which hospitalized patients should be in the ICU? * which antibiotics are appropriate initial therapy for children with pneumonia? This app is written and intended for practicing clinicians like family physicians, internists, pediatricians, ER docs, and hospitalists; for resident physician trainees; and for medical students. As an educator and clinician, I am interested in feedback and I would be grateful for guidance on improving the tool.

The ACC DAPT Risk Calculator provides clinical decision support for clinicians evaluating the continuation of DAPT therapy for patients at least 12 months post-PCI procedure, and the risk/benefit of continuing or discontinuing DAPT. The App provides a DAPT Risk Score as a numerical value between -2 and +9, where a Higher DAPT scores suggest that the benefit/risk ratio with prolonged DAPT may be favorable. Conversely, lower DAPT scores suggest that the benefit/risk ratio with prolonged DAPT is NOT favorable. The clinical decision support tool also calculates the percentage of risk for three end points: - Myocardial infarction (MI) - Stent thrombosis, major adverse cardiovascular and cerebrovascular events (MACCE) - Bleeding